ALB and Hypoalbuminemia: Only a small fraction of our participants (3%) had hypoalbuminemia (serum albumin <3.5 g/dL), similar to the START study (2%) and the D:A:D trial (6%), suggesting that these patients are relatively healthy overall and would unlikely benefit from nutritional support to increase serum albumin.